|
1
|
Huth-Kühne A, Baudo F, Collins P,
Ingerslev J, Kessler CM, Lévesque H, Castellano ME, Shima M and
St-Louis J: International recommendations on the diagnosis and
treatment of patients with acquired hemophilia A. Haematologica.
94:566–575. 2009.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ogawa Y, Yanagisawa K, Uchiumi H, Ishizaki
T, Mitsui T, Gouda F, Ieko M, Ichinose A, Nojima Y and Handa H:
Clinical characteristics and outcomes of acquired hemophilia A:
experience at a single center in Japan. Int J Hematol. 106:82–89.
2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ogawa Y, Amano K, Matsuo-Tezuka Y, Okada
N, Murakami Y, Nakamura T, Yamaguchi-Suita H and Nogami K: ORIHIME
study: Real-world treatment patterns and clinical outcomes of 338
patients with acquired hemophilia A from a Japanese administrative
database. Int J Hematol. 117:44–55. 2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tiede A, Werwitzke S and Scharf RE:
Laboratory diagnosis of acquired hemophilia A: Limitations,
consequences, and challenges. Semin Thromb Hemost. 40:803–811.
2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tiede A, Collins P, Knoebl P, Teitel J,
Kessler C, Shima M, Di Minno G, d'Oiron R, Salaj P, Jiménez-Yuste
V, et al: International recommendations on the diagnosis and
treatment of acquired hemophilia A. Haematologica. 105:1791–1801.
2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Delgado J, Jimenez-Yuste V,
Hernandez-Navarro F and Villar A: Acquired haemophilia: Review and
meta-analysis focused on therapy and prognostic factors. Br J
Haematol. 121:21–35. 2003.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Collins PW, Hirsch S, Baglin TP, Dolan G,
Hanley J, Makris M, Keeling DM, Liesner R, Brown SA and Hay CR: UK
Haemophilia Centre Doctors' Organisation. Acquired hemophilia A in
the United Kingdom: A 2-year national surveillance study by the
United Kingdom Haemophilia Centre Doctors' Organisation. Blood.
109:1870–1877. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bossi P, Cabane J, Ninet J, Dhote R,
Hanslik T, Chosidow O, Jouan-Flahault C, Horellou MH, Leynadier F,
Liozon E, et al: Acquired hemophilia due to factor VIII inhibitors
in 34 patients. Am J Med. 105:400–408. 1998.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Morrison AE, Ludlam CA and Kessler C: Use
of porcine factor VIII in the treatment of patients with acquired
hemophilia. Blood. 81:1513–1520. 1993.PubMed/NCBI
|
|
10
|
Green D and Lechner K: A survey of 215
non-hemophilic patients with inhibitors to Factor VIII. Thromb
Haemost. 45:200–203. 1981.PubMed/NCBI
|
|
11
|
Miura T, Ban D, Koyama T, Kudo A, Ochiai
T, Irie T, Nakamura N, Tanaka S and Arii S: Severe postoperative
hemorrhage caused by antibody-mediated coagulation factor
deficiencies: Report of two cases. Surg Today. 44:976–981.
2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mekenkamp LJ, Beishuizen A, Slomp J,
Legdeur MC, Klaase JM and Trof RJ: Successful treatment of
fulminant postoperative bleeding due to acquired haemophilia. Neth
J Med. 73:182–186. 2015.PubMed/NCBI
|
|
13
|
Suzuki N, Hirakawa A, Kishimoto M,
Kanematsu T, Ogawa M, Kiyoi H and Matsushita T: Retrospective
analysis of in vivo recovery and clearance during continuous
infusion of recombinant factor VIII products: A single-institution
study. Haemophilia. 23:215–221. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Napolitano M, Siragusa S, Mancuso S and
Kessler CM: Acquired haemophilia in cancer: A systematic and
critical literature review. Haemophilia. 24:43–56. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Geethakumari PR, Sama A, Caro JG, Yeo CJ
and Nagalla S: ‘The Immune Conundrum’: Acquired Hemophilia A,
immune thrombocytopenia, and neutropenia in a patient with
pancreatic cancer. Case Rep Pancreat Cancer. 2:14–18.
2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sallah S: Treatment of acquired
haemophilia with factor eight inhibitor bypassing activity.
Haemophilia. 10:169–173. 2004.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tiede A and Worster A: Lessons from a
systematic literature review of the effectiveness of recombinant
factor VIIa in acquired haemophilia. Ann Hematol. 97:1889–1901.
2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kruse-Jarres R, St-Louis J, Greist A,
Shapiro A, Smith H, Chowdary P, Drebes A, Gomperts E, Bourgeois C,
Mo M, et al: Efficacy and safety of OBI-1, an antihaemophilic
factor VIII (recombinant), porcine sequence, in subjects with
acquired haemophilia A. Haemophilia. 21:162–170. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Tiede A, Klamroth R, Scharf RE, Trappe RU,
Holstein K, Huth-Kühne A, Gottstein S, Geisen U, Schenk J, Scholz
U, et al: Prognostic factors for remission of and survival in
acquired hemophilia A (AHA): Results from the GTH-AH 01/2010 study.
Blood. 125:1091–1097. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Collins P, Baudo F, Knoebl P, Lévesque H,
Nemes L, Pellegrini F, Marco P, Tengborn L and Huth-Kühne A:
Immunosuppression for acquired hemophilia A: Results from the
European Acquired Haemophilia Registry (EACH2). Blood. 120:47–55.
2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Franchini M: Acquired hemophilia A.
Hematology. 11:119–125. 2006.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Gok E, Akay MH, de Armas IS, Klein K, Tint
H, Allison PM, Chen AJ, Akkanti B, Kar B and Gregoric ID: Aortic
root repair in a patient with acquired hemophilia A: case report.
Surg Case Rep. 7(176)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tjønnfjord GE, Brinch L, Gedde-Dahl T and
Brosstad FR: Activated prothrombin complex concentrate (FEIBA)
treatment during surgery in patients with inhibitors to FVIII/IX.
Haemophilia. 10:174–178. 2004.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hay CR, Negrier C and Ludlam CA: The
treatment of bleeding in acquired haemophilia with recombinant
factor VIIa: A multicentre study. Thromb Haemost. 78:1463–1467.
1997.PubMed/NCBI
|
|
25
|
Ichikawa S, Kohata K, Okitsu Y, Suzuki M,
Nakajima S, Yamada MF, Onishi Y, Yamamoto J, Suzuki S, Ishizawa K,
et al: Acquired hemophilia A with sigmoid colon cancer: Successful
treatment with rituximab followed by sigmoidectomy. Int J Hematol.
90:33–36. 2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Jena SS, Meher D and Dhankar N: Unforeseen
encounter of acquired hemophilia A in a preoperative case of
periampullary carcinoma: A case report. Int J Surg Case Rep.
79:146–149. 2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kruse-Jarres R, Kempton CL, Baudo F,
Collins PW, Knoebl P, Leissinger CA, Tiede A and Kessler CM:
Acquired hemophilia A: Updated review of evidence and treatment
guidance. Am J Hematol. 92:695–705. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Shen M, Wang S, Sessa J, Hanna A, Axelrad
A and Ali F: Acquired hemophilia A: A case report. J Pharm Pract.
33:562–566. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Prencipe MA, D'Errico M, Di Giorgio G,
Gatta G, Gesuete A, Nobile M and Stallone C: Macrohaematuria
post-partum: An unusual case of acquired haemophilia after
pregnancy. G Ital Nefrol. 19:204–208. 2002.PubMed/NCBI(In Italian).
|
|
30
|
Baudo F, Collins P, Huth-Kühne A, Lévesque
H, Marco P, Nemes L, Pellegrini F, Tengborn L and Knoebl P: EACH2
registry contributors. Management of bleeding in acquired
hemophilia A: results from the European Acquired Haemophilia
(EACH2) Registry. Blood. 120:39–46. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lindahl R, Nummi V, Lehtinen AE, Szanto T,
Hiltunen L, Olsson A, Glenthoej A, Chaireti R, Vaide I, Funding E
and Zetterberg E: Acquired Haemophilia A in four north European
countries: Survey of 181 patients. Br J Haematol. 201:326–333.
2023.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Guerra JD, Gowarty J, Buess J, Mason J and
Halka K: A case of acquired hemophilia a in a patient with exposure
to COVID-19. Case Rep Hematol. 2022(9494249)2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Murali A, Wong P, Gilbar PJ and Mangos HM:
Acquired Hemophilia A following Pfizer-BioNTech SARS CoV-2 mRNA
vaccine, successfully treated with prednisolone and rituximab. J
Oncol Pharm Pract. 28:1450–1453. 2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Franchini M, Cappello E, Valdiserra G,
Bonaso M, Moretti U, Focosi D and Tuccori M: Investigating a signal
of acquired hemophilia associated with COVID-19 Vaccination: A
systematic case review. Semin Thromb Hemost. 49:15–26.
2023.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Shoji-Asahina A, Nakatani E, Imaichi Y,
Ohata E, Oshima M, Miyakoshi A, Miyake H, Ichikawa Y, Dote H,
Ubukata N, et al: Risk factors, treatment and survival rates of
late-onset acquired haemophilia A: A cohort study from the Shizuoka
Kokuho Database. Haemophilia. 29:799–808. 2023.PubMed/NCBI View Article : Google Scholar
|
